Hiku Archives

Debra BorchardtJuly 11, 2018

Canopy Growth Corporation (CGC) is acquiring Hiku Brands Company Ltd. (HIKU.CN) and paying a premium for the shares. Canopy is paying C$1.91 per share, which is a 33% premium based on the average price over a 20-day period. Hiku shareholders will receive 0.046 each of a Canopy Growth share. Consequently, WeedMD has terminated its plans […]

Debra BorchardtJune 25, 2018

It’s time for your Daily Hit of financial cannabis news for June 25, 2018. On The Site GW Pharmaceuticals If any other company released any news today, then it went basically unnoticed because the FDA approved GW Pharmaceutical’s (GWPH) cannabidiol drug Epidiolex. The news was expected sometime this week, so it was nice of the FDA […]

William SumnerMay 31, 2018

The luxury cannabis company Hiku Brands Ltd. (HIKU) announced the filing of its financial results for the quarter ending on March 31, 2018. “The first quarter of 2018 was one that focused on solidifying our vertically integrated cannabis company and positioning us to win in the legal adult-use market in Canada.” said Alan Gertner, CEO […]

StaffMarch 7, 2018

This is your quick hit of news for March 7, 2018. Marapharm Ventures Inc. Marapharm Ventures (MRPHF) gave a progress report on its Washington facility. The copany said that the rehabilitation of the cultivation site will be completed by the end of March. “During the renovation, we have worked closely with our architect and engineering […]

Lykos Therapeutics Secures $100M in Series A Funding, Rebrands from MAPS PBC

Functional Mushrooms Move Into Mainstream as Wellness Trend Grows

In other news

The Daily Hit: January 4, 2024

Connecticut Attorney General Tells Unlicensed Cannabis Events Company to Stop

Testing Concerns Lead to Quarantine for 70% of Mississippi MMJ Goods

Tag: Hiku

Canopy Growth Pays Premium For Hiku Brands

The Daily Hit: June 25, 2018

Hiku Brands Squeaks Out Gross Profit In Q1, But Posts Big Net Loss

The Daily Hit: Today’s Cannabis Briefs

The Daily Hit - TEST TEST TEST

Lykos Therapeutics Secures $100M in Series A Funding, Rebrands from MAPS PBC

Functional Mushrooms Move Into Mainstream as Wellness Trend Grows

Get the latest cannabis news delivered right to your inbox

Get the latest cannabis news delivered right to your inbox